Welcome to LookChem.com Sign In|Join Free

CAS

  • or

73746-45-9

Post Buying Request

73746-45-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73746-45-9 Usage

General Description

2-Methyl-4(5)-iodo-1(H)-imidazole is a chemical compound with the molecular formula C4H5IN2. It is a derivative of imidazole and is commonly used as a building block in organic synthesis. It is a white to off-white crystalline powder with a molecular weight of 217.99 g/mol. The compound is primarily used in the pharmaceutical industry for the synthesis of various pharmaceuticals, including antifungal and antibacterial agents. It is also used as a reagent in the synthesis of other organic compounds and as a corrosion inhibitor. Additionally, 2-Methyl-4(5)-iodo-1(H)-imidazole has potential applications in the development of new materials and drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 73746-45-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,7,4 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 73746-45:
(7*7)+(6*3)+(5*7)+(4*4)+(3*6)+(2*4)+(1*5)=149
149 % 10 = 9
So 73746-45-9 is a valid CAS Registry Number.
InChI:InChI=1/C4H5IN2/c1-3-6-2-4(5)7-3/h2H,1H3,(H,6,7)

73746-45-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-iodo-2-methyl-1H-imidazole

1.2 Other means of identification

Product number -
Other names 5-iodo-2-methyl-1H-imidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73746-45-9 SDS

73746-45-9Relevant articles and documents

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1

Peng, Yi-Hui,Ueng, Shau-Hua,Tseng, Chen-Tso,Hung, Ming-Shiu,Song, Jen-Shin,Wu, Jian-Sung,Liao, Fang-Yu,Fan, Yu-Shiou,Wu, Mine-Hsine,Hsiao, Wen-Chi,Hsueh, Ching-Cheng,Lin, Shu-Yu,Cheng, Chia-Yi,Tu, Chih-Hsiang,Lee, Lung-Chun,Cheng, Ming-Fu,Shia, Kak-Shan,Shih, Chuan,Wu, Su-Ying

, p. 282 - 293 (2016/01/29)

Indoleamine 2,3-dioxygenase 1 (IDO1), promoting immune escape of tumors, is a therapeutic target for the cancer immunotherapy. A number of IDO1 inhibitors have been identified, but only limited structural biology studies of IDO1 inhibitors are available t

Discovery of MK-5046, a potent, selective bombesin receptor subtype-3 agonist for the treatment of obesity

Sebhat, Iyassu K.,Franklin, Christopher,Lo, Michael M.-C.,Chen, David,Jewell, James P.,Miller, Randy,Pang, Jianmei,Palyha, Oksana,Kan, Yanqing,Kelly, Theresa M.,Guan, Xiao-Ming,Marsh, Donald J.,Kosinski, Jennifer A.,Metzger, Joseph M.,Lyons, Kathryn,Dragovic, Jasminka,Guzzo, Peter R.,Henderson, Alan J.,Reitman, Marc L.,Nargund, Ravi P.,Wyvratt, Matthew J.,Lin, Linus S.

supporting information; experimental part, p. 43 - 47 (2011/04/17)

We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-

Substituted inmidazoles as bombesin receptor subtype-3 modulators

-

Page/Page column 27-28, (2010/02/17)

Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73746-45-9